Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 3.62% vs 11.61% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 3.59% vs 131.50% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 2.37% vs 176.75% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 8.36% vs -17.53% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Shandong Buchang Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 3.62% vs 11.61% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2.95% vs -18.60% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 3.59% vs 131.50% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 221.52% vs -62.28% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 2.37% vs 176.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 45.63% vs -16.01% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 8.36% vs -17.53% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -6.33% vs 26.24% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






